Search Results - "Qian, Qijun"
-
1
Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor
Published in Cell death & disease (17-06-2019)“…Mesothelin (MSLN) is an attractive antigen for chimeric antigen receptor (CAR) T therapy and the epitope selection within MSLN is essential. In this study, we…”
Get full text
Journal Article -
2
Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy
Published in Journal of translational medicine (18-02-2021)“…Although chimeric antigen receptor (CAR)-T cell therapy has been remarkably successful for haematological malignancies, its efficacy against solid tumors is…”
Get full text
Journal Article -
3
An efficient Screening System in Yeast to Select a Hyperactive piggyBac Transposase for Mammalian Applications
Published in International journal of molecular sciences (26-04-2020)“…As non-viral transgenic vectors, the transposon system represents an attractive tool for gene delivery to achieve a long-term gene expression in immunotherapy…”
Get full text
Journal Article -
4
Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients
Published in PloS one (22-12-2016)“…Cellular immunotherapy has appeared to be a promising modality for the treatment of malignant tumor. The objective of this study was to evaluate the efficacy…”
Get full text
Journal Article -
5
Rapid response in relapsed follicular lymphoma with massive chylous ascites to anti-CD19 CAR T therapy using Piggy Bac: A case report
Published in Frontiers in immunology (01-12-2022)“…CD19-directed chimeric antigen receptor (CAR) T cell therapy has been shown to achieve a considerably durable response in patients with refractory or relapsed…”
Get full text
Journal Article -
6
Evaluation of Nonviral piggyBac and lentiviral Vector in Functions of CD19chimeric Antigen Receptor T Cells and Their Antitumor Activity for CD19 + Tumor Cells
Published in Frontiers in immunology (10-01-2022)“…Nonviral transposon (PB) and (LV) vectors have been used to deliver chimeric antigen receptor (CAR) to T cells. To understand the differences in the effects of…”
Get full text
Journal Article -
7
αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib
Published in Journal for immunotherapy of cancer (01-02-2021)“…Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological malignancies in China. In particular, advanced/refractory ovarian cancer…”
Get full text
Journal Article -
8
Single-cell RNA-Seq reveals the potential risk of anti-mesothelin CAR T Cell therapy toxicity to different organs in humans
Published in Frontiers in immunology (17-08-2022)“…“On-target off-tumor” toxicity is a major challenge to the use of chimeric antigen receptor (CAR)-engineered T cells in the treatment of solid malignancies,…”
Get full text
Journal Article -
9
PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report
Published in Frontiers in immunology (25-05-2021)“…MYC/BCL2/BCL6 triple-hit lymphoma (THL) is an uncommon subset of high-grade B-cell lymphoma with aggressive clinical behavior and poor prognosis. TP53 mutation…”
Get full text
Journal Article -
10
Triggered Immune Response Induced by Antigenic Epitopes Covalently Linked with Immunoadjuvant-Pulsed Dendritic Cells as a Promising Cancer Vaccine
Published in Journal of immunology research (2020)“…The success of peptide-based dendritic cell (DC) cancer vaccines mainly depends on the utilized peptides and selection of an appropriate adjuvant. Herein, we…”
Get full text
Journal Article -
11
Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia
Published in Oncotarget (01-06-2013)“…An attractive strategy among adenovirus-based oncolytic systems is to design adenoviral vectors to express pro-apoptotic genes, in which this gene-virotherapy…”
Get full text
Journal Article -
12
Therapeutic Mechanism of Nucleic Acid Drugs
Published in ChemistrySelect (Weinheim) (04-02-2021)“…Abstract Nucleic acid drugs were a class of DNA/RNA molecules and considered able to be applied for protein‐related diseases treatment through regulating…”
Get full text
Journal Article -
13
Scalable manufacturing methodologies for improving adeno-associated virus-based pharmaprojects
Published in Science bulletin (Beijing) (01-06-2014)“…Adeno-associated virus (AAV) is a promising viral vector and meets most requirements of being a safe biological agent. However, the commercialization of AAV…”
Get full text
Journal Article -
14
Safety and Efficacy of an Immune Cell-Specific Chimeric Promoter in Regulating Anti-PD-1 Antibody Expression in CAR T Cells
Published in Molecular therapy. Methods & clinical development (11-12-2020)“…T cells modified to co-express cytokine or other factors with chimeric antigen receptor (CAR) can induce substantial and persistent increases in antitumor…”
Get full text
Journal Article -
15
Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells
Published in Journal of translational medicine (11-08-2015)“…Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. HCC has a poor prognosis associated with tumor recurrence and drug resistance,…”
Get full text
Journal Article -
16
Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells
Published in PloS one (21-07-2011)“…Highly selective therapy for hepatocellular carcinoma (HCC) remains an unmet medical need. In present study, we found that the tumor suppressor microRNA, let-7…”
Get full text
Journal Article -
17
Correction: Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor
Published in Cell death & disease (16-04-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
18
P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells
Published in Gut (01-05-2011)“…Hepatocellular carcinoma (HCC) is one of the most malignant tumours with high rate of recurrence and metastasis. In HCC, deficiency of the P16/CDK4/Rb pathway…”
Get more information
Journal Article -
19
hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers
Published in PloS one (10-08-2011)“…Human sulfatase 1 (hSulf-1) is a heparin-degrading endosulfatase that desulfates cell surface heparan sulfate proteoglycans (HSPGs) in extracellular matrix and…”
Get full text
Journal Article -
20
A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers
Published in Molecular cancer therapeutics (01-06-2008)“…Conditionally replicating adenoviruses (CRAd) can replicate specifically in cancer cells and lyse them. The CRAds were widely used in the preclinical and…”
Get full text
Journal Article